View Research Programmes
Laboratory Details
Translational Oncology Laboratory

Translational oncology from bench to bedside

The Cancer Biology Research Group investigates precise molecular vulnerabilities in human malignancies, bridging laboratory assays and clinical trials to replace empirical chemotherapy with targeted patient care.

Research Output

Quantifiable translational impact

Core Disciplines

Three interconnected investigative pillars

Our laboratory operates across molecular discovery, high-throughput computational genomics, and translational clinical diagnostics.

Cellular Pathways
Precision Profiling
Bedside Delivery

Molecular Tumour Biology

Genomic Stratification

Targeted Theranostics

Characterising the intracellular signalling networks and metabolic shifts that permit oncogenic transformation and acquired drug resistance.

Applying deep next-generation sequencing cohorts to match tumour mutational signatures against selective pharmacological dependencies.

Synthesising paired diagnostic radiotracers and targeted therapeutic compounds to simultaneously visualise and neutralize malignant cells.

Clinical Purpose

Data matters only when it shifts a clinical decision at the bedside.

Every genomic pipeline, assay cohort, and molecular screen in our facility is oriented toward clarifying therapeutic trajectories for individual patients and their treating oncology teams.

Contact Our Laboratory

Initiate an academic or clinical dialogue

We welcome enquiries regarding trial referrals, doctoral fellowships, and multi-institutional research collaborations.